Carbamazepine intoxication with negative myoclonus after the addition of clobazam

Epilepsia

Volumn 39, Issue 10, 1998, Pages 1115-1118

  Genton, Pierre ^a   Nguyen, Vi Huong ^a   Mesdjian, Edouard ^b  

^a CENTRE SAINT PAUL   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Carbamazepine; Clobazam; Drug interaction; Epilepsy; Negative myoclonus

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; TOPIRAMATE;

AGED; ANTICONVULSANT THERAPY; ARTICLE; CASE REPORT; COMPLEX PARTIAL SEIZURE; DRUG BLOOD LEVEL; HUMAN; MALE; MYOCLONUS; PRIORITY JOURNAL;

AGED; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; BENZODIAZEPINES; BENZODIAZEPINONES; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; MALE; MYOCLONUS;

EID: 3543067463     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01299.x     Document Type: Article

References (13)

1. Holmes GL. Carbamazepine toxicity. In: Lévy RL, Mattson RH, Meldrum BS, eds. Antiepileptic drugs. 4th ed. New York: Raven Press, 1995:567-79.
2. Mesdjian E, Dravet C, Cenraud B, Roger J. Carbamazepine intoxication due to triacetyloleandomycin administration in epileptic patients. Epilepsia 1980;21:489-96.
3. Levy RH, Moreland TA, Morselli PH, Guyot M, Brachet-Liermain A, Loiseau P. Carbamazepine-valproic acid interaction in man and rhesus monkay. Epilepsia 1984;25:338-45.
4. Wolf P, Beck-Managetta G, Meencke J, Röder UU, Rohland C, Schmidt D. Erfahrungen mit der Anwendung von Clobazam (Frisium) als Antiepileptikum. In: Renschmidt H, Rentz R, Jungmann J, eds. Epilepsie 1980. Psychosoziale Aspekte, posttraumatische Epilepsien, medikamentöse Behandlung, diagnostische Methoden. Stuttgart: Thieme, 1981:164-71.
5. Sennoune S, Mesdjian E, Bonneton J, Genton P, Dravet C, Roger J. Interactions between clobazam and standard antiepileptic drugs in patients with epilepsy. Ther Drug Monit 1992;14:269-74.
6. Guerrini R, Belmonte A, Strumia S, Hirsch E. Exacerbation of epileptic negative myoclonus in children with atypical benign rolandic epilepsy. Epilepsia 1995;36(suppl 3):S65.
7. Dhuna A, Pascual-Leone A, Taiwar D. Exacerbation of partial seizures and onset of nonepileptic myclonus with carbamazepine. Epilepsia 1991;32:275-8.
8. Vakil SD, Critchley EMR, Cocks A, Hayward HW. The effect of clobazam on blood levels of phenobarbitone, phenytoin and carbamazepine (preliminary report). In: Hindmarch I, Stonier PD, eds. Clobazam. London: The Royal Society of Medicine (International Congress and Symposium Series Number 43), 1981:165-7.
9. Wilson A, Dellaportas CI, Clifford Rose F. Low dose clobazam as adjunctive treatment in chronic epilepsy. In: Hindmarch I, Stonier PD, Trimble MR, eds. Clobazam: human psychoparmacology and clinical applications. London: The Royal Society of Medicine (International Congress and Symposium Series Number 74) 1985:173-8.
10. Munoz JJ, De Salamanca RE, Diaz-Obregön C, Timoneda FL. The effect of clobazam on steady state plasma concentrations of carbamazepine and its metabolites. Br J Clin Pharmacol 1990;29:763-5.
11. Goggin T, Callaghan N. Blood levels of clobazam and its metabolites and therapeutic effect. In: Hindmarch I, Stonier PD, Trimble MR, eds. Clobazam: human spychopharmacology and clinical applications. London: The Royal Society of Medicine (International Congress and Symposium Series Number 74) 1985:149-53.
12. Zifkin B, Sherwin A, Andermann F. Phenytoin toxicity due to interaction with clobazam. Neurology 1991;41:313-4.
13. Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984;47: 1279-82.